IRIDEX CORP Announces Director Changes and Compensatory Arrangements

Ticker: IRIX · Form: 8-K · Filed: Jun 13, 2025 · CIK: 1006045

Iridex Corp 8-K Filing Summary
FieldDetail
CompanyIridex Corp (IRIX)
Form Type8-K
Filed DateJun 13, 2025
Risk Levelmedium
Sentimentneutral

Sentiment: neutral

Topics: director-change, board-election, compensation

Related Tickers: IRIX

TL;DR

IRIDEX CORP board shakeup: Wilson out, Dolnik & Wilson in, new pay deals.

AI Summary

On June 11, 2025, IRIDEX CORP filed an 8-K report detailing several key events. The company announced the departure of Director David L. Wilson, effective June 7, 2025. Additionally, the company elected two new directors, Robert J. Dolnik and David J. L. Wilson, to its Board of Directors, effective June 11, 2025. The filing also disclosed compensatory arrangements for certain officers.

Why It Matters

Changes in board composition and executive compensation can signal shifts in company strategy or governance, potentially impacting investor confidence and future performance.

Risk Assessment

Risk Level: medium — Director departures and new appointments, along with changes in compensatory arrangements, can introduce uncertainty regarding future strategy and leadership stability.

Key Players & Entities

  • IRIDEX CORP (company) — Registrant
  • David L. Wilson (person) — Departing Director
  • Robert J. Dolnik (person) — Newly Elected Director
  • David J. L. Wilson (person) — Newly Elected Director
  • June 11, 2025 (date) — Effective date of director elections
  • June 7, 2025 (date) — Effective date of director departure

FAQ

Who has departed from IRIDEX CORP's Board of Directors?

David L. Wilson has departed from the Board of Directors, with his departure effective June 7, 2025.

Who has been elected as new directors to IRIDEX CORP's Board?

Robert J. Dolnik and David J. L. Wilson have been elected as new directors, effective June 11, 2025.

What is the effective date for the election of the new directors?

The election of Robert J. Dolnik and David J. L. Wilson to the Board of Directors is effective as of June 11, 2025.

What other information is disclosed in this 8-K filing besides director changes?

The filing also discloses compensatory arrangements for certain officers.

What is the principal executive office address for IRIDEX CORP?

The principal executive offices are located at 1212 Terra Bella Avenue, Mountain View, California 94043.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on June 13, 2025 by David L. Wilson regarding IRIDEX CORP (IRIX).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.